Работы, на которые ссылается эта работа
Работ: 100
Работа: Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy
Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning +7
Статья2024Цитирований: 8ABIDissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi +8
Обзорная статья2022Цитирований: 6ABITargeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Kaveh Hadiloo, Parsa Mostanadi, Ali Asadzadeh +2
Обзорная статья2025Цитирований: 6ABITargeting cancer stem cell pathways for cancer therapy
Liqun Yang, Pengfei Shi, Gaichao Zhao +8
Обзорная статья2020Цитирований: 5ABIMechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Xinyi Xiao, Shengkang Huang, Sifei Chen +4
Обзорная статья2021Цитирований: 5ABICAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang +2
Обзорная статья2024Цитирований: 5ABICancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Gh. Rasool Bhat, Itty Sethi, Hana Q. Sadida +14
Обзорная статья2024Цитирований: 5ABIThe clinical landscape of CAR NK cells
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob +1
Обзорная статья2025Цитирований: 5ABIThe tumor microenvironment’s role in the response to immune checkpoint blockade
Konstantinos Aliazis, Anthos Christofides, Rushil Shah +4
Обзорная статья2025Цитирований: 4ABILong-term outcomes following CAR T cell therapy: what we know so far
Kathryn M. Cappell, James N. Kochenderfer
Обзорная статья2023Цитирований: 3ABICancer Stem Cell Plasticity Drives Therapeutic Resistance
Mary R. Doherty, Jacob Smigiel, Damian J. Junk +1
Обзорная статья2016Цитирований: 3ABIFrom ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
Eleonora Pinto, Lisa A. Lione, Mirco Compagnone +8
Обзорная статья2025Цитирований: 3ABIPD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
Yongshuai Jiang, Ming Chen, Hong Nie +1
Обзорная статья2019Цитирований: 2ABIMicroenvironmental regulation of therapeutic response in cancer
Florian Klemm, Johanna A. Joyce
Обзорная статья2014Цитирований: 2ABIThe NF-κB Pathway and Cancer Stem Cells
Amanda L. Rinkenbaugh, Albert S. Baldwin
Обзорная статья2016Цитирований: 2ABITargeting cancer stem cells in drug discovery: Current state and future perspectives
Fangyu Du, Qifan Zhou, Wenjiao Sun +1
Обзорная статья2019Цитирований: 2ABICellular and molecular mechanisms of plasticity in cancer
Stefan Torborg, Zhuxuan Li, Jason E. Chan +1
Обзорная статья2022Цитирований: 2ABITowards Immunotherapy-Induced Normalization of the Tumor Microenvironment
Vinicio Melo, Edwin Bremer, John D. Martin
Обзорная статья2022Цитирований: 2ABIMetabolic challenges and interventions in CAR T cell therapy
Jhan-Jie Peng, Limei Wang, Zhiyu Li +2
Обзорная статья2023Цитирований: 2ABICAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance
Diane Coursier, Fernando Calvo
Обзорная статья2024Цитирований: 2ABIEngineered Cytokine Signaling to Improve CAR T Cell Effector Function
Matthew Bell, Stephen Gottschalk
Обзорная статья2021Цитирований: 2ABIImproving CAR T-Cell Persistence
Violena Pietrobon, Lauren A. Todd, Anghsumala Goswami +3
Обзорная статья2021Цитирований: 2ABI